We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$80.2B
AUM Growth
+$2.8B
Cap. Flow
+$296M
Cap. Flow %
0.37%
Top 10 Hldgs %
9.83%
Holding
4,048
New
499
Increased
1,419
Reduced
1,452
Closed
416

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$667M
2
NVDA icon
NVIDIA
NVDA
+$584M
3
COP icon
ConocoPhillips
COP
+$432M
4
AMZN icon
Amazon
AMZN
+$418M
5
JNJ icon
Johnson & Johnson
JNJ
+$377M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$836M
2
META icon
Meta Platforms (Facebook)
META
+$525M
3
AAPL icon
Apple
AAPL
+$453M
4
CELG
Celgene Corp
CELG
+$349M
5
PFE icon
Pfizer
PFE
+$306M

Sector Composition

Rank Sector Weight
1 Technology 15.58%
2 Consumer Discretionary 13.65%
3 Healthcare 12.98%
4 Industrials 7.3%
5 Financials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCPC
3876
CALL
Balchem Corp
BCPC
$5.23B
-2,600
Closed -$241K
IVAC
3877
DELISTED
Intevac Inc
IVAC
-99,814
Closed -$612K
SBT
3878
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
-15,930
Closed -$162K
CDMO
3879
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-14,493
Closed -$62K
MRO
3880
CALL
DELISTED
Marathon Oil Corporation
MRO
-82,400
Closed -$1.38M
MRO
3881
PUT
DELISTED
Marathon Oil Corporation
MRO
-56,800
Closed -$949K
SAVE
3882
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
-4,100
Closed -$217K
HA
3883
DELISTED
Hawaiian Holdings, Inc.
HA
-27,306
Closed -$742K
ASXC
3884
DELISTED
Asensus Surgical, Inc.
ASXC
-1,568
Closed -$49K
MDC
3885
DELISTED
M.D.C. Holdings, Inc.
MDC
-42,639
Closed -$1.15M
CBD
3886
DELISTED
Companhia Brasileira de Distribuicao
CBD
-9,478
Closed -$221K
DSKE
3887
DELISTED
Daseke, Inc. Common Stock
DSKE
-10,357
Closed -$53K
SIEN
3888
CALL
DELISTED
Sientra, Inc.
SIEN
-4,500
Closed -$386K
MRTX
3889
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-3,763
Closed -$293K
SRC
3890
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-6,583
Closed -$262K
HT
3891
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
-31,737
Closed -$544K
NEWR
3892
CALL
DELISTED
New Relic, Inc.
NEWR
-2,300
Closed -$227K
RAD
3893
DELISTED
Rite Aid Corporation
RAD
-2,652
Closed -$34K
RETA
3894
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-24,329
Closed -$2.1M
INFI
3895
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-10,210
Closed -$19K
KDNY
3896
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-17,407
Closed -$346K
PDCE
3897
CALL
DELISTED
PDC Energy, Inc.
PDCE
-34,000
Closed -$1.38M
UNVR
3898
DELISTED
Univar Solutions Inc.
UNVR
-12,100
Closed -$268K
USX
3899
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-36,675
Closed -$242K
HEXO
3900
DELISTED
HEXO Corp. Common Shares
HEXO
-28,493
Closed -$10.6M

Similar funds

D.E. Shaw & Co's Q2 2019 Portfolio in Review

As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
  • D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
  • D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
  • D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
  • D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
  • D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
  • D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.